Loading...
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk
Recent advances in proteomic technologies have made high-throughput profiling of low-abundance proteins in large epidemiological cohorts increasingly feasible. We investigated whether aptamer-based proteomic profiling could identify biomarkers associated with future development of type 2 diabetes (T...
Na minha lista:
| Udgivet i: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8021115/ https://ncbi.nlm.nih.gov/pubmed/33591955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.144392 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|